Literature DB >> 11877407

Similar structural basis for membrane localization and protein priming by an RNA-dependent RNA polymerase.

John M Lyle1, Amy Clewell, Kathryn Richmond, Oliver C Richards, Debra A Hope, Steve C Schultz, Karla Kirkegaard.   

Abstract

Protein primers are used to initiate genomic synthesis of several RNA and DNA viruses, although the structural details of the primer-polymerase interactions are not yet known. Poliovirus polymerase binds with high affinity to the membrane-bound viral protein 3AB but uridylylates only the smaller peptide 3B in vitro. Mutational analysis of the polymerase identified four surface residues on the three-dimensional structure of poliovirus polymerase whose wild-type identity is required for 3AB binding. These mutants also decreased 3B uridylylation, arguing that the binding sites for the membrane tether and the protein primer overlap. Mutation of flanking residues between the 3AB binding site and the polymerase active site specifically decreased 3B uridylylation, likely affecting steps subsequent to binding. The physical overlap of sites for protein priming and membrane association should facilitate replication initiation in the membrane-associated complex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877407     DOI: 10.1074/jbc.M112429200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Sequence requirements for viral RNA replication and VPg uridylylation directed by the internal cis-acting replication element (cre) of human rhinovirus type 14.

Authors:  Yan Yang; Rene Rijnbrand; Kevin L McKnight; Eckard Wimmer; Aniko Paul; Annette Martin; Stanley M Lemon
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

2.  Intracellular topology and epitope shielding of poliovirus 3A protein.

Authors:  Sunny S Choe; Karla Kirkegaard
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  Strand-specific RNA synthesis defects in a poliovirus with a mutation in protein 3A.

Authors:  Natalya L Teterina; Mario S Rinaudo; Ellie Ehrenfeld
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

4.  NMR solution structure of poliovirus uridylyated peptide linked to the genome (VPgpU).

Authors:  Catherine H Schein; Numan Oezguen; Gerbrand J van der Heden van Noort; Dmitri V Filippov; Aniko Paul; Eric Kumar; Werner Braun
Journal:  Peptides       Date:  2010-05-02       Impact factor: 3.750

Review 5.  Expanding knowledge of P3 proteins in the poliovirus lifecycle.

Authors:  Craig E Cameron; Hyung Suk Oh; Ibrahim M Moustafa
Journal:  Future Microbiol       Date:  2010-06       Impact factor: 3.165

6.  Crystal structure of complete rhinovirus RNA polymerase suggests front loading of protein primer.

Authors:  Todd C Appleby; Hartmut Luecke; Jae Hoon Shim; Jim Z Wu; I Wayne Cheney; Weidong Zhong; Lutz Vogeley; Zhi Hong; Nanhua Yao
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  Allosteric effects of ligands and mutations on poliovirus RNA-dependent RNA polymerase.

Authors:  Joanna E Boerner; John M Lyle; Sarah Daijogo; Bert L Semler; Stephen C Schultz; Karla Kirkegaard; Oliver C Richards
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

8.  Characterization of the expression, intracellular localization, and replication complex association of the putative mouse hepatitis virus RNA-dependent RNA polymerase.

Authors:  Sarah M Brockway; Corrie T Clay; Xiao Tao Lu; Mark R Denison
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Surface for catalysis by poliovirus RNA-dependent RNA polymerase.

Authors:  Jing Wang; John M Lyle; Esther Bullitt
Journal:  J Mol Biol       Date:  2013-04-11       Impact factor: 5.469

10.  Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome.

Authors:  Meike Hass; Michaela Lelke; Carola Busch; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.